India has a heavy TB burden but has the technological capacity to deal with it. T.V. Padma reports.

New TB vaccines are facing a major funding shortfall, says Mićo Tatalović, and some countries seem resistant to accepting a future vaccine.

South Africa is using nanotechnology to improve existing tuberculosis drugs. Munyaradzi Makoni looks at a developing country's experience.

With proper supervision, developing countries' students can excel and contribute to science research, as the recent TB genome mapping shows.

As tuberculosis strains that are resistant to all known drugs continue to emerge, scientists are trying new approaches to drug development.

Text messaging to ensure that TB patients in developing countries take their medication every day is showing promise in trials.

Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.

Bovine tuberculosis is no less dangerous to humans than common TB, but relatively little is known about it, reports Natasha Bolognesi.

Priya Shetty looks at the prevalence and distribution of tuberculosis in the developing world, outlining the truths — and myths — about this disease.

Jill McGivering and Ed Cropley report on how fake drugs and poor education increase resistance to antimalarials in South-East Asia.